Boglar Champ ended 2024 with RON149 million turnover, up from RO134 million in 2023 and RON14.5 million net profit, from RON16.8 million, and targets RON170 million turnover in 2025, up 14% from 2023.
Otopeni handling companies raked in revenues worth almost RON340 million in 2024, up 20% yoy.
Dr. Max Group, which includes the pharmacies of the same name and drug wholesaler Mediplus, ended 2024 with over EUR2 billion (RON10.7 billion) turnover, after a 23% advance from 2023.